Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

NVO CEO exits amid pressure. Sanofi is set to buy VIGL. Pfizer inks $1.25B 3SBio deal. FDA okays Roche eye drug for new indication. Merck starts key cancer study.

Investment research Market and company reports Stock market data Share Exchange ...

During the third quarter, the Lazard International Equity Advantage Portfolio underperformed the MSCI EAFE Index (net of fees ...

Nvidia slipped in early morning trading after Chinese quantitative trading fund Goku submitted a new AI research paper. Investors can stay up-to-date with all of the latest stock market news at ...